SQUARCIALUPI, LUCIA
 Distribuzione geografica
Continente #
NA - Nord America 2.264
EU - Europa 1.403
AS - Asia 1.041
SA - Sud America 139
AF - Africa 35
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.903
Nazione #
US - Stati Uniti d'America 2.235
RU - Federazione Russa 451
IT - Italia 291
CN - Cina 246
VN - Vietnam 246
SG - Singapore 230
IE - Irlanda 198
HK - Hong Kong 125
SE - Svezia 116
BR - Brasile 113
PL - Polonia 112
KR - Corea 63
DE - Germania 61
FI - Finlandia 55
FR - Francia 49
IN - India 43
GB - Regno Unito 34
JP - Giappone 22
AU - Australia 20
CA - Canada 17
JO - Giordania 14
AR - Argentina 12
MA - Marocco 9
MX - Messico 9
TR - Turchia 9
BD - Bangladesh 8
CI - Costa d'Avorio 8
ID - Indonesia 8
ES - Italia 7
NL - Olanda 7
PK - Pakistan 6
UA - Ucraina 6
ZA - Sudafrica 6
EC - Ecuador 5
IQ - Iraq 5
EE - Estonia 4
AZ - Azerbaigian 3
CH - Svizzera 3
BE - Belgio 2
BO - Bolivia 2
EG - Egitto 2
KG - Kirghizistan 2
SA - Arabia Saudita 2
SN - Senegal 2
TH - Thailandia 2
UY - Uruguay 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AW - Aruba 1
BH - Bahrain 1
BJ - Benin 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
LT - Lituania 1
MD - Moldavia 1
ME - Montenegro 1
MU - Mauritius 1
NG - Nigeria 1
PE - Perù 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 4.903
Città #
Santa Clara 545
Ashburn 289
Dublin 197
Singapore 157
Fairfield 152
Dong Ket 148
Chandler 141
Warsaw 111
Hong Kong 104
Beijing 99
Cambridge 81
San Jose 76
Milan 75
Seattle 72
Woodbridge 72
Wilmington 70
Seoul 62
Houston 58
Los Angeles 44
Munich 42
The Dalles 40
Ho Chi Minh City 36
Florence 32
New York 31
Princeton 31
Rome 31
Dallas 30
Mumbai 29
Altamura 24
Boston 24
Ann Arbor 23
Lauterbourg 23
Lawrence 23
Hanoi 22
Paris 22
Shanghai 22
Tokyo 21
Helsinki 20
Buffalo 19
Melbourne 19
Medford 14
Council Bluffs 12
Hefei 12
Kent 12
Turku 11
Boardman 10
Moscow 10
Abidjan 8
West Jordan 8
Casablanca 7
Chennai 7
Clifton 7
Figino 7
Turin 7
São Paulo 6
Amsterdam 5
Atlanta 5
Barcelona 5
Chicago 5
Montreal 5
Poplar 5
Stockholm 5
Tianjin 5
Toronto 5
Amman 4
Bari 4
Belo Horizonte 4
Da Nang 4
Jakarta 4
Johannesburg 4
Querétaro 4
Romola 4
San Diego 4
San Francisco 4
Tallinn 4
Brooklyn 3
Cagliari 3
Chongqing 3
Curitiba 3
Denver 3
Guangzhou 3
Guarulhos 3
London 3
Manchester 3
Naples 3
Redondo Beach 3
Rio de Janeiro 3
Verona 3
Washington 3
Baghdad 2
Baku 2
Bangkok 2
Bauru 2
Bern 2
Boca Raton 2
Bologna 2
Bremen 2
Brussels 2
Catania 2
City of London 2
Totale 3.408
Nome #
1,2,4-Benzothiadiazine-1,1-dioxide Derivatives as Ionotropic Glutamate Receptor Ligands: Synthesis and Structure–Activity Relationships 298
The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A2A Receptor Subtype 275
Characterization by flow cytometry of fluorescent, selective agonist probes of the A3 adenosine receptor 267
3-Hydroxy-1H-quinazoline-2,4-dione as a New Scaffold to Develop Potent and Selective Inhibitors of the Tumor-Associated Carbonic Anhydrases IX and XII 228
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles 227
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino Derivatives As New Potent and Selective Human A3Adenosine Receptor Antagonists. Molecular Modeling Studies and Pharmacological Evaluation 226
3-Hydroxy-1H-quinazoline-2,4-dione derivatives as new antagonists at ionotropic glutamate receptors: Molecular modeling and pharmacological studies. 221
1,2,4-Triazolo[4,3-a]pyrazin-3-one as a new scaffold to develop potent adenosine receptor antagonists 217
A comprehensive strategy in the development of a cyclodextrin-modified microemulsion electrokinetic chromatographic method for the assay of diclofenac and its impurities: Mixture-process variable experiments and quality by design 210
1,2,4-Triazolo[1,5-a]quinoxaline derivatives and their simplified analogues as adenosine A3 receptor antagonists. Synthesis, structure–affinity relationships and molecular modeling studies 208
7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: Structural investigations at the 5-position to target human A1 and A2A adenosine receptors. Molecular modeling and pharmacological studies 173
Exploring the 7-oxo-thiazolo[5,4-d]pyrimidine core for the design of new human adenosine A3 receptor antagonists. Synthesis, molecular modeling studies and pharmacological evaluation 170
3-Hydroxy-1H-quinazoline-2,4-dione derivatives as new potent and selective inhibitors of the tumor-associated carbonic anhydrase IX and XII. 169
Synthesis, structure-affinity relationships, and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists. 165
4-Alkyloxyimino-cytosine nucleotides: tethering approaches to molecular probes for the P2Y6 receptor 161
Pyrazolo[1,5-c]quinazoline derivatives and their simplified analogues as adenosine receptor antagonists: Synthesis, structure–affinity relationships and molecular modeling studies 153
Fluorescent ligands for adenosine receptors 145
2-Hydroxy-1,2,4-benzothiadiazin-1,1-dioxide derivatives as new antagonists of ionotropic glutamate receptors 143
2-Arylimidazo[1,2-a]pyrazin-8-amino derivatives as high-affinity fluorescent human A3 adenosine receptor antagonists with potential neuroprotective properties 138
New 5-heteroaryl-pyrazolo[4,3-d]pyrimidin-7-amines as dual human adenosine A1 and A2A receptor antagonists. 137
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives, new potent and selective human A3 adenosine receptor antagonists endowed with protective effect against oxaliplatin-induced apoptosis in rat astrocyte cell cultures 133
Imidazo[1,2-a]pyrazine core for the design of new adenosine receptor antagonist: optimization of A3 affinity and structural exploration to target the A2A subtype 129
Arilpirazolo[4,3-d]pirimidin-7-ammino derivati quali nuovi antagonisti potenti e selettivi del recettore umano A3 dell’adenosina 124
Quality by Design and Mixture-Process Variable approach in the development of a cyclodextrin-MEEKC method for the assay of diclofenac and its impurities 119
Structural investigations on 2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new human adenosine receptor antagonists. 116
Exploring the effect of 2- and 5-substituents on the pyrazolo[4,3-d]pyrimidin-7-amino derivatives to obtain human adenosine receptor antagonists 108
Thiazolo[5,4-d]pyrimidin-7-amino derivatives as new human A2A adenosine receptor antagonists 101
null 90
Synthesis and Pharmacological evaluation of some new 8-substitute-7-trifluoromethyl-4,5-dihydro-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates as AMPA/Kainate receptor antagonists 83
Totale 4.934
Categoria #
all - tutte 13.503
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.503


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022187 5 20 28 11 6 7 4 9 9 6 23 59
2022/2023553 48 98 34 33 47 90 78 48 51 2 13 11
2023/2024247 8 15 26 5 11 111 4 28 6 10 15 8
2024/20251.439 39 158 78 183 442 218 32 51 46 49 88 55
2025/20261.526 197 198 102 172 144 55 158 57 110 89 31 213
2026/202720 20 0 0 0 0 0 0 0 0 0 0 0
Totale 4.934